3 employees
Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.
2005
$28M
from 2 investors over 2 rounds
Cardioxyl Pharmaceuticals, Inc. raised $28M on November 13, 2012
Investors: Osage University Partners (OUP) and OrbiMed Advisors